Christopher S. Keenan
Profile
Christopher S.
Keenan held positions in investor relations and corporate communications at Avid Bioservices, Cytokinetics, Assertio Therapeutics, and CytomX Therapeutics.
Former positions of Christopher S. Keenan
| Companies | Position | End |
|---|---|---|
| AVID BIOSERVICES, INC. | Public Communications Contact | 31/05/2015 |
| CYTOMX THERAPEUTICS, INC. | Investor Relations Contact | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Investor Relations Contact | - |
| CYTOKINETICS, INCORPORATED | Investor Relations Contact | 30/10/2011 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| AVID BIOSERVICES, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
- Stock Market
- Insiders
- Christopher S. Keenan
